The article discusses the health issues of Nemesio Oseguera Cervantes, known as ‘El Mencho’, leader of the Jalisco New Generation Cartel (CJNG), and the discovery of Tationil Plus, a drug found in his refuge.
In February 2025, a year prior to the death of ‘El Mencho’, Omar García Harfuch, the head of Mexico's Security and Citizen Protection Secretariat, confirmed that ‘El Mencho’ was suffering from a renal deficiency but did not provide specifics regarding his illness. During a press conference, he addressed rumors about the drug lord's health, stating there were no new revelations other than the known kidney deficiency. This highlights the public concern surrounding the health of one of the most notorious cartel leaders in Mexico.
Previously, reports from 2020 indicated that ‘El Mencho’ had constructed a private hospital meant for his exclusive use in El Alcíhuatl, a community within Villa Purificación, Jalisco. Intelligence from the Security Cabinet was aware of the clinic's existence as early as 2019. This suggests that 'El Mencho' was anticipating serious health issues that required specialized medical attention, which adds complexity to the understanding of his operations and lifestyle as a drug lord.
Moreover, the mention of Tationil Plus, a medication typically used for treating liver conditions, found in his hideout raises questions about the specific health problems he faced. The discovery of such a drug not only deepens the intrigue regarding 'El Mencho's' personal life but also reflects on the broader implications of the health of cartel leaders, who often operate under significant stress and risk, impacting their longevity and ability to lead their organizations.
